Harmony Biosciences Holdings, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating income was USD 23.312 million compared to USD 7.309 million a year ago. Net income was USD 14.117 million compared to net loss of USD 27,000 a year ago. Basic earnings per share from continuing operations was USD 0.25 compared to basic loss per share from continuing operations of USD 1.34 a year ago. Diluted earnings per share from continuing operations was USD 0.24 compared to diluted loss per share from continuing operations of USD 1.34 a year ago. For the half year, operating income was USD 37.844 million compared to operating loss of USD 1.154 million a year ago. Net income was USD 21.503 million compared to net loss of USD 38.647 million a year ago. Basic earnings per share from continuing operations was USD 0.38 compared to basic loss per share from continuing operations of USD 7.63 a year ago. Diluted earnings per share from continuing operations was USD 0.37 compared to diluted loss per share from continuing operations of USD 7.63 a year ago.